18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma
-
- KIKUCHI Masahiro
- Department of Otolaryngology, Head and Neck Surgery, Kobe City Medical Center General Hospital
-
- YAMANE Tomohiko
- Division of Molecular Imaging, Institute of Biomedical Research and Innovation
-
- SHINOHARA Shogo
- Department of Otolaryngology, Head and Neck Surgery, Kobe City Medical Center General Hospital
-
- FUJIWARA Keizo
- Department of Otolaryngology, Head and Neck Surgery, Kobe City Medical Center General Hospital
-
- HORI Shin-ya
- Department of Otolaryngology, Shizuoka General Hospital
-
- TONA Yosuke
- Department of Otolaryngology, Shizuoka General Hospital
-
- YAMAZAKI Hiroshi
- Department of Otolaryngology, Head and Neck Surgery, Kobe City Medical Center General Hospital
-
- NAITO Yasushi
- Department of Otolaryngology, Head and Neck Surgery, Kobe City Medical Center General Hospital
-
- SENDA Michio
- Division of Molecular Imaging, Institute of Biomedical Research and Innovation
この論文をさがす
収録刊行物
-
- Annals of nuclear medicine
-
Annals of nuclear medicine 25 (9), 625-633, 2011-11-01
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1571417125763533952
-
- NII論文ID
- 10030232978
-
- NII書誌ID
- AA10708017
-
- ISSN
- 09147187
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles